UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049671
Receipt number R000056526
Scientific Title Study on the Diagnosis of Non-Specific Abdominal Pain and Acute Hepatic Porphyria
Date of disclosure of the study information 2022/12/03
Last modified on 2023/08/17 11:04:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the Diagnosis of Non-Specific Abdominal Pain and Acute Hepatic Porphyria

Acronym

Study on the Diagnosis of Non-Specific Abdominal Pain and Acute Hepatic Porphyria

Scientific Title

Study on the Diagnosis of Non-Specific Abdominal Pain and Acute Hepatic Porphyria

Scientific Title:Acronym

Study on the Diagnosis of Non-Specific Abdominal Pain and Acute Hepatic Porphyria

Region

Japan


Condition

Condition

Abdominal pain

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We conducts this survey to suggest the definition of unexplained abdominal pain.

Basic objectives2

Others

Basic objectives -Others

Diagnostics

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Non-Specific Abdominal Pain

Key secondary outcomes

Acute Hepatic Porphyria


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who visited the Department of General Medicine of institutions from April 1, 2019 to March 31, 2022, and underwent either an abdominal CT scan, upper GI endoscopy, lower GI endoscopy, or abdominal ultrasound are included.

Key exclusion criteria

Patients who offer refusal to participate.

Target sample size

900


Research contact person

Name of lead principal investigator

1st name Susumu
Middle name
Last name Tazuma

Organization

MEDICAL CORPORATION JR HIROSHIMA HOSPITAL / JA Onomichi General Hospital

Division name

Hospital DirectorHonorary / Director,Advisor

Zip code

732-0057 / 722-8508

Address

3-1-36 Futabanosato, Higashi-ku, Hiroshima, Hiroshima / 1-10-23 Hirahara, Onomichi, Hiroshima

TEL

082-262-1171.0848-22-8111

Email

stazuma@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Masaki
Middle name
Last name Tago

Organization

Saga University Hospital

Division name

Department of General Medicine

Zip code

849-0937

Address

5-1-1 Nabeshima, Saga-shi, Saga

TEL

0952-31-6511

Homepage URL


Email

tagomas@cc.saga-u.ac.jp


Sponsor or person

Institute

Saga University Hospital

Institute

Department

Personal name



Funding Source

Organization

Alnylam Japan K.K.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Center, Saga University Hospital

Address

5-1-1 Nabeshima, Saga-shi, Saga

Tel

0952-34-3400

Email

clinstudycenter@mail.admin.saga-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

JA尾道総合病院(広島県)
佐賀大学医学部附属病院(佐賀県)
東邦大学医療センター大森病院(東京都)
福岡大学病院(福岡県)
順天堂大学医学部附属順天堂医院(東京都)
獨協医科大学病院(栃木県)


Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 11 Month 28 Day

Date of IRB

2022 Year 12 Month 05 Day

Anticipated trial start date

2023 Year 01 Month 10 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Items of information to be obtained
Basic information regarding abdominal pain
-Age, sex, height, and body weight
-Route of transport to the medical institution
-Confirmed diagnosis. If a case does not have a confirmed diagnosis, we will collect the item unexplained abdominal pain.
-Suspected diseases
-Number of visits
-Whether or not the patient was referred to the Department of General Medicine
-Whether or not the patient has a history of visiting other departments
-Time of initial presentation of abdominal pain symptoms
-Number of incidences of abdominal pain

Test items
Whether or not the following tests have been performed so far:
-Electrocardiogram
-Blood tests
-Urine tests
-Abdominal imaging tests
-Pelvic ultrasound

Abdominal pain findings

Concurrent symptoms other than abdominal pain


Management information

Registered date

2022 Year 12 Month 02 Day

Last modified on

2023 Year 08 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056526


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name